Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-24 11:33 am Purchase | 13G | RAIN ONCOLOGY INC. RAIN | BML Investment Partners L.P. | 1,815,953 6.6% | 1,815,953 (New Position) | View |
| 2023-10-02 11:45 am Purchase | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners L.P. | 4,183,645 5% | 4,183,645 (New Position) | View |
| 2023-09-15 12:00 pm Unchanged | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,735,075 4.78% | 0 (Unchanged) | View |
| 2023-07-24 3:23 pm Purchase | 13G | AVROBIO INC AVRO | BML Investment Partners L.P. | 3,965,396 9% | 3,965,396 (New Position) | View |
| 2023-07-17 11:07 am Purchase | 13G | QUINCE THERAPEUTICS, INC QNCX | BML Investment Partners L.P. | 1,841,301 5.07% | 1,841,301 (New Position) | View |
| 2023-06-26 4:00 pm Unchanged | 13D | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners L.P. | 232,065 13.7% | 0 (Unchanged) | View |
| 2023-06-12 6:57 pm Sale | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | BML Investment Partners L.P. | 0 0% | -6,590,000 (Position Closed) | View |
| 2023-04-27 2:19 pm Unchanged | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners L.P. | 2,189,193 5.2% | 0 (Unchanged) | View |
| 2023-04-27 10:55 am Purchase | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners L.P. | 2,189,193 5.2% | 2,189,193 (New Position) | View |
| 2023-03-29 11:17 am Purchase | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,735,075 8.26% | 273,711 (+18.73%) | View |
| 2023-03-17 10:15 am Purchase | 13G | EMBARK TECHNOLOGY INC EMBK | BML Investment Partners L.P. | 994,355 5.2% | 994,355 (New Position) | View |
| 2023-02-08 5:29 pm Sale | 13G | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners L.P. | 232,065 13.7% | -5,247,257 (-95.76%) | View |
| 2023-02-08 5:24 pm Unchanged | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners L.P. | 0 0% | 0 (Unchanged) | View |
| 2023-02-08 5:23 pm Sale | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners L.P. | 0 0% | -1,764,274 (Position Closed) | View |
| 2023-02-08 5:09 pm Unchanged | 13G | PARDES BIOSCIENCES INC PRDS | BML Investment Partners L.P. | 4,867,984 7.8% | 0 (Unchanged) | View |
| 2023-02-08 5:06 pm Unchanged | 13G | GRAYBUG VISION INC GRAY | BML Investment Partners L.P. | 1,235,943 5.7% | 0 (Unchanged) | View |
| 2023-02-08 4:55 pm Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | BML Investment Partners L.P. | 6,590,000 19.9% | 150,000 (+2.33%) | View |
| 2023-02-08 4:44 pm Purchase | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners L.P. | 7,300,179 7.3% | 2,124,679 (+41.05%) | View |
| 2023-02-08 4:35 pm Purchase | 13G | ELIEM THERAPEUTICS INC ELYM | BML Investment Partners L.P. | 1,897,614 7.1% | 158,236 (+9.10%) | View |
| 2023-02-08 4:16 pm Purchase | 13G | IMARA INC IMRA | BML Investment Partners L.P. | 3,337,774 12.7% | 157,774 (+4.96%) | View |